Als Ftd Overlap Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Amyotrophic lateral sclerosis and [frontotemporal dementia](/diseases/frontotemporal-dementia) represent opposite ends of a disease spectrum with significant clinical, pathological, and genetic overlap. Understanding the vulnerable neuron populations in this spectrum is crucial for developing targeted therapies. [@corf2021]
Overview
The ALS-FTD spectrum represents a continuum of neurodegenerative diseases: [@tdp2023]
Pure ALS: ~70% of cases
ALS-FTD Overlap: ~15% of ALS patients meet criteria for FTD
FTD-ALS: ~15% of FTD patients have ALS features
Pure FTD: Without motor neuron involvement
Key Shared Features
Genetics: [C9orf72](/genes/c9orf72) is the major shared genetic cause
Pathology: [TDP-43](/proteins/tardbp) protein inclusions
Als Ftd Overlap Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Amyotrophic lateral sclerosis and [frontotemporal dementia](/diseases/frontotemporal-dementia) represent opposite ends of a disease spectrum with significant clinical, pathological, and genetic overlap. Understanding the vulnerable neuron populations in this spectrum is crucial for developing targeted therapies. [@corf2021]
Overview
The ALS-FTD spectrum represents a continuum of neurodegenerative diseases: [@tdp2023]
Pure ALS: ~70% of cases
ALS-FTD Overlap: ~15% of ALS patients meet criteria for FTD
FTD-ALS: ~15% of FTD patients have ALS features
Pure FTD: Without motor neuron involvement
Key Shared Features
Genetics: [C9orf72](/genes/c9orf72) is the major shared genetic cause
Pathology: [TDP-43](/proteins/tardbp) protein inclusions
Antipsychotics: Psychosis management in [FTD](/diseases/frontotemporal-dementia)
Speech Therapy: Communication support
Occupational Therapy: Daily function
Biomarkers
Neurofilament Light Chain: Disease progression in [ALS](/diseases/amyotrophic-lateral-sclerosis)
CSF TDP-43: Pathology marker
PET Tracers: Inflammatory, metabolic
EEG/EMG: Electrophysiological markers
Background
The study of Als Ftd Overlap Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@motor2022]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@frontotemporal2023]